360b / Shutterstock.com
Representatives from the pharmaceutical and engineering industries have said that the decision to opt existing patents into the Unified Patent Court (UPC) will be a strategic decision done on a case-by-case basis.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
CIPA; UPC; GSK; BAe; patents; pharmaceuticals; engineering; NPEs